{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T13:40:16Z","timestamp":1725198016245},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"DOI":"10.7759\/cureus.68382","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T13:20:57Z","timestamp":1725196857000},"source":"Crossref","is-referenced-by-count":0,"title":["Brief Psychotic Episodes and Depressed Mood in a Patient With Borderline Personality Disorder and Antiphospholipid Syndrome"],"prefix":"10.7759","author":[{"given":"William","family":"Borchert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L","family":"Megna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luba","family":"Leontieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\"","volume":"32","author":"Cervera R","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plas\u00edn MA, et al.. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\". J Autoimmun. 2009, 32:240-5. 10.1016\/j.jaut.2009.02.008","journal-title":"J Autoimmun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit JY","year":"2022","unstructured":"Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-Garc\u00eda A. Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep. 2022, 23:85. 10.1007\/s11926-021-01038-2","journal-title":"Curr Rheumatol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda A","year":"2019","unstructured":"Duarte-Garc\u00eda A, Pham MM, Crowson CS, et al.. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 2019, 71:1545-52. 10.1002\/art.40901","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.11.013","article-title":"The geoepidemiology of the antiphospholipid antibody syndrome","volume":"9","author":"Biggioggero M","year":"2010","unstructured":"Biggioggero M, Meroni PL. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev. 2010, 9:A299-304. 10.1016\/j.autrev.2009.11.013","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12010091","article-title":"Neuropsychiatric manifestations of antiphospholipid syndrome-a narrative review","volume":"12","author":"Man YL","year":"2022","unstructured":"Man YL, Sanna G. Neuropsychiatric manifestations of antiphospholipid syndrome-a narrative review. Brain Sci. 2022, 12:10.3390\/brainsci12010091","journal-title":"Brain Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03349.x","article-title":"Autoimmunity in depression: increased antiphospholipid autoantibodies","volume":"87","author":"Maes M","year":"1993","unstructured":"Maes M, Meltzer H, Jacobs J, Suy E, Calabrese J, Minner B, Raus J. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr Scand. 1993, 87:160-6. 10.1111\/j.1600-0447.1993.tb03349.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?","volume":"44","author":"Ferreira S","year":"2005","unstructured":"Ferreira S, D'Cruz DP, Hughes GR. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?. Rheumatology (Oxford). 2005, 44:434-42. 10.1093\/rheumatology\/keh532","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association, Washington DC; 2022."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.04.017","article-title":"Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: a narrative review","volume":"127","author":"Saccaro LF","year":"2021","unstructured":"Saccaro LF, Schilliger Z, Dayer A, Perroud N, Piguet C. Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: a narrative review. Neurosci Biobehav Rev. 2021, 127:184-92. 10.1016\/j.neubiorev.2021.04.017","journal-title":"Neurosci Biobehav Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01503-z","article-title":"Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors","volume":"27","author":"Tate AE","year":"2022","unstructured":"Tate AE, Sahlin H, Liu S, et al.. Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors. Mol Psychiatry. 2022, 27:2514-21. 10.1038\/s41380-022-01503-z","journal-title":"Mol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1475_20","article-title":"Acute psychosis as the presenting manifestation of lupus","volume":"10","author":"Kumar P","year":"2021","unstructured":"Kumar P, Kumar A, Thakur V, Sharma CB, Thomas A, Chatterjee S. Acute psychosis as the presenting manifestation of lupus. J Family Med Prim Care. 2021, 10:1050-3. 10.4103\/jfmpc.jfmpc_1475_20","journal-title":"J Family Med Prim Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(15)50445-3","article-title":"Neuropsychiatric presentations of antiphospholipid antibodies","volume":"135","author":"Gris J-C","year":"2015","unstructured":"Gris J-C, Nobile B, Bouvier S. Neuropsychiatric presentations of antiphospholipid antibodies. Thromb Res. 2015, 135:56-9. 10.1016\/S0049-3848(15)50445-3","journal-title":"Thromb Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu409oa","article-title":"Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer","volume":"12","author":"Shoenfeld Y","year":"2003","unstructured":"Shoenfeld Y, Nahum A, Korczyn AD, et al.. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus. 2003, 12:436-42. 10.1191\/0961203303lu409oa","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2017.11.005","article-title":"Association of psychosis with antiphospholipid antibody syndrome: a systematic review of clinical studies","volume":"50","author":"Hallab A","year":"2018","unstructured":"Hallab A, Naveed S, Altibi A, et al.. Association of psychosis with antiphospholipid antibody syndrome: a systematic review of clinical studies. Gen Hosp Psychiatry. 2018, 50:137-47. 10.1016\/j.genhosppsych.2017.11.005","journal-title":"Gen Hosp Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia D","year":"2018","unstructured":"Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018, 378:2010-21. 10.1056\/NEJMra1705454","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1037\/pro0000430","article-title":"Adverse childhood experiences, risk factors in the onset of autoimmune diseases in adults: a meta-analysis","volume":"53","author":"Macarenco MM","year":"2022","unstructured":"Macarenco MM, Opariuc-Dan C, Nedelcea C. Adverse childhood experiences, risk factors in the onset of autoimmune diseases in adults: a meta-analysis. Prof Psychol Res Pract. 2022, 53:69-79. 10.1037\/pro0000430","journal-title":"Prof Psychol Res Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000344","article-title":"Adverse childhood experiences and neurocognition in borderline personality disorder: a call-to-action perspective review","volume":"30","author":"Estric C","year":"2022","unstructured":"Estric C, Calati R, Lopez-Castroman J. Adverse childhood experiences and neurocognition in borderline personality disorder: a call-to-action perspective review. Harv Rev Psychiatry. 2022, 30:248-60. 10.1097\/HRP.0000000000000344","journal-title":"Harv Rev Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/248796-brief-psychotic-episodes-and-depressed-mood-in-a-patient-with-borderline-personality-disorder-and-antiphospholipid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T13:21:01Z","timestamp":1725196861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/248796-brief-psychotic-episodes-and-depressed-mood-in-a-patient-with-borderline-personality-disorder-and-antiphospholipid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.68382","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}